Mucinous adenocarcinoma is a rare subtype accounting for 2-10% of lung adenocarcinomas. Tumor cells produce abundant mucin and fill alveoli with mucin, creating a consolidation pattern — hence its reputation as a 'pneumonia mimic'. It typically presents multifocally or bilaterally. CT angiogram sign (enhancing vessels within consolidation) is pathognomonic. KRAS mutation is common while EGFR mutation is rare. Prognosis is worse than conventional adenocarcinoma. Formerly known as bronchioloalveolar carcinoma (BAC) mucinous type.
Age Range
40-75
Peak Age
60
Gender
Equal
Prevalence
Uncommon
Mucinous adenocarcinoma consists of goblet-like mucin-producing cells. These cells secrete abundant mucinous material into alveolar spaces — alveolar lumina fill with mucin creating consolidation. The tumor spreads in a lepidic pattern along existing alveolar walls, but filling of alveolar lumina with mucin makes the consolidation indistinguishable from pneumonia. Air bronchograms form when patent bronchi are surrounded by mucin-filled alveoli. CT angiogram sign results from pulmonary vessels within the consolidation filling with contrast as they traverse the mucinous consolidation — this finding can also be seen in infectious consolidation but is pathognomonic in persistent consolidation. Aerogenous spread (aspiration of tumor cells within mucin from one lobe to another) is the mechanism of multifocal and bilateral disease.
The 'angiogram-like' prominent visualization of enhancing pulmonary vessels within low-density mucinous consolidation is the pathognomonic finding of mucinous adenocarcinoma. This sign results from the large contrast difference between the very low density of mucinous content (0-20 HU) and the high density of enhancing vessels (150-300 HU). The combination of persistent consolidation + CT angiogram sign, especially with multifocal/bilateral involvement, establishes the diagnosis of mucinous adenocarcinoma with high confidence.
Consolidation pattern: Lobar or segmental consolidation resembling pneumonia. Usually lower lobe predilection. Consolidation density may be lower than infectious consolidation (<20 HU) because mucinous content is near water density. Consolidation borders may be irregular or geographic. Persistent consolidation lasting weeks to months should raise suspicion for malignancy.
Report Sentence
Persistent consolidation in the ___ lobe is identified with low-density characteristics; in the presence of antibiotic-unresponsive persistent consolidation, mucinous adenocarcinoma should be considered in the differential diagnosis.
CT angiogram sign: Pulmonary vessels within the consolidation become visible by enhancing — enhancing vessels against low-density mucinous consolidation background create an 'angiogram-like' appearance. Pathognomonic finding. Best seen on pulmonary arterial phase of contrast-enhanced CT. Vessels are normal, not occluded or invaded — the low density of consolidation provides contrast to vessels.
Report Sentence
Enhancing pulmonary vessels within the consolidation area are prominently visualized (CT angiogram sign); this pathognomonic finding supports the diagnosis of mucinous adenocarcinoma.
Multifocal/bilateral distribution: Consolidation/nodular lesions in multiple lobes or bilaterally. Aerogenous spread pattern — spread from one lobe to another through aspiration of tumor cells within mucin. Crazy-paving pattern (ground-glass + interlobular septal thickening) may accompany. Bilateral disease indicates poor prognosis.
Report Sentence
Multifocal consolidation areas in bilateral lungs with accompanying crazy-paving pattern are identified, consistent with mucinous adenocarcinoma demonstrating aerogenous spread.
Prominent air bronchograms within consolidation: Patent bronchi surrounded by mucin-filled alveoli. Branching pattern is prominent. Bronchi are usually normal (not obstructed) — this distinguishes from atelectasis due to endobronchial obstruction. Mucin filling within some bronchi (intrabronchial high density) may be visible.
Report Sentence
Prominent air bronchograms within the consolidation area are identified with no bronchial obstruction; consistent with mucinous adenocarcinoma demonstrating lepidic spread.
Variable FDG uptake on PET-CT: Low to moderate FDG uptake in consolidation areas (SUVmax 1.5-5). Lower FDG uptake than solid adenocarcinoma due to low cellularity of mucinous content — a false-negative pitfall. Variable uptake pattern in multifocal lesions. Limited sensitivity for staging but useful for distant metastasis screening.
Report Sentence
Low to moderate FDG uptake is seen in consolidation areas (SUVmax: ___); FDG uptake in mucinous adenocarcinoma may be lower than conventional adenocarcinoma, and the possibility of false-negative results should be considered.
Crazy-paving pattern: Thickened interlobular and intralobular septa against a ground-glass background. In mucinous adenocarcinoma, results from the combination of alveolar mucin accumulation (ground-glass) + septal tumor infiltration (septal thickening). Should be differentiated from pulmonary alveolar proteinosis and lipoid pneumonia.
Report Sentence
Interlobular and intralobular septal thickening on a ground-glass background (crazy-paving pattern) is identified, and mucinous adenocarcinoma should be considered in the differential diagnosis.
Criteria
Single lobar/segmental consolidation. No aerogenous spread. Usually early stage.
Distinct Features
Single localized consolidation on CT, curative treatment possible with surgical resection. Better prognosis than multifocal type. CT angiogram sign present. Differentiation from infectious pneumonia: persistent consolidation unresponsive to antibiotics.
Criteria
Consolidation foci in multiple lobes or bilaterally. Aerogenous spread mechanism.
Distinct Features
Multifocal/bilateral consolidation areas on CT, low density, CT angiogram sign. Surgical resection usually not possible. Chemotherapy is primary treatment. Poor prognosis. Crazy-paving pattern may accompany.
Criteria
Presents as single or multiple solid/part-solid nodules rather than consolidation. Less common presentation.
Distinct Features
Solid or part-solid nodules on CT, may be indistinguishable from conventional adenocarcinoma on imaging. Diagnosis is histopathological (mucin production). Low-density areas within the nodule (mucinous pools) may be a clue.
Distinguishing Feature
Organizing pneumonia also shows consolidation but is typically peripheral/subpleural, migratory, and responsive to corticosteroid therapy. CT angiogram sign is prominent in mucinous adenocarcinoma but usually not seen in organizing pneumonia. Multifocal distribution and persistent consolidation suggest mucinous adenocarcinoma.
Distinguishing Feature
Conventional adenocarcinoma presents as a spiculated nodule/mass, consolidation is rare. Mucinous adenocarcinoma shows consolidation pattern, low density, positive CT angiogram sign, tendency to be multifocal. KRAS mutation is common in mucinous type, EGFR mutation rare (opposite in conventional type).
Distinguishing Feature
Pulmonary lymphoma can show consolidation or nodular pattern. Air bronchograms are common in lymphoma but CT angiogram sign is not typical. Mediastinal/hilar lymphadenopathy is more prominent in lymphoma. LAP is not prominent in mucinous adenocarcinoma.
Distinguishing Feature
Pulmonary metastases are usually multiple smooth-margined nodules, consolidation pattern is rare (except GI tract mucinous carcinomas). Known primary malignancy history is distinguishing. In mucinous adenocarcinoma, consolidation pattern is dominant and CT angiogram sign is characteristic.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralSurgical resection (lobectomy) is curative in unifocal mucinous adenocarcinoma. Surgery is usually not feasible in multifocal/bilateral disease — chemotherapy is the primary treatment. Targeted therapy (sotorasib) may be applied if KRAS G12C mutation is present, but EGFR-TKI response is low as EGFR mutation is rare. Immunotherapy (based on PD-L1 expression) has been added to standard treatment. Biopsy (transbronchial or CT-guided) in persistent consolidation is critical for diagnosis. Bronchoalveolar lavage (BAL) cytology may be helpful for diagnosis (mucin-producing malignant cells). Multidisciplinary tumor board evaluation is required.
Mucinous adenocarcinoma generally has worse prognosis than non-mucinous adenocarcinoma. KRAS mutation is common, EGFR mutation is rare. Surgery (early stage), chemotherapy, and immunotherapy are treatment options.